Publications
4 shownNiraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Among patients with newly diagnosed advanced ovarian cancer who had a response to platinum-based chemotherapy, those who received niraparib had significantly longer progression-...
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
In patients with advanced ovarian cancer receiving first-line standard therapy including bevacizumab, the addition of maintenance olaparib provided a significant progression-fre...
Frequent Co-Authors
Researcher Info
- h-index
- 4
- Publications
- 4
- Citations
- 7,438
- Institution
- KU Leuven
External Links
Identifiers
- ORCID
- 0000-0002-7589-8981
Impact Metrics
h-index
4
h-index: Number of publications with at least h citations each.